During the past decade, Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital" #1 sponsor was "Shire" with 3 trials, followed by "Abivax S.A." with 2 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital" are "Ulcerative Colitis" (9 trials), "Crohn's Disease" (1 trials), "Primary Generalized Tonic Clonic Seizures in the Setting of Idiopathic Generalized Epilepsy" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital" are "Drug" (12 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Etrasimod" (3 trials), "Ontamalimab" (3 trials), "Etrolizumab" (2 trials) and "ABX464" (1 trials). Other intervention names were less common.

The vast majority of trials in "Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 6 completed trials in Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Communal Non-commercial Enterprise of Kharkiv Regional Council Regional Clinical Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".